Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial
Maron, D. J., Spertus, J. A., Mancini, G. B. J., Hartigan, P. M., Sedlis, S. P., Bates, E. R., … Boden, W. E. (2009). Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial. AMERICAN JOURNAL OF CARDIOLOGY, 104(8), 1055–1062.

Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Maron, D. J., Boden, W. E., Spertus, J. A., Hartigan, P. M., Mancini, G. B. J., Sedlis, S. P., … O'Rourke, R. A. (2011). Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(2), 131–137.

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE Trial
Mancini, G. B. J., Hartigan, P. M., Bates, E. R., Sedlis, S. P., Maron, D. J., Spertus, J. A., … Boden, W. E. (2011). Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy Observations From the COURAGE Trial. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 4(6), 545–552.

Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists
Maron, D. J., Stone, G. W., Berman, D. S., Mancini, G. B. J., Scott, T. A., Byrne, D. W., … Spertus, J. A. (2011). Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a Web-based survey of cardiologists. AMERICAN HEART JOURNAL, 162(6), 1034–U124.

Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention
Shaw, L. J., Weintraub, W. S., Maron, D. J., Hartigan, P. M., Hachamovitch, R., Min, J. K., … Berman, D. S. (2012). Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. AMERICAN HEART JOURNAL, 164(2), 243–250.

Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial
Spertus, J. A., Maron, D. J., Cohen, D. J., Kolm, P., Hartigan, P., Weintraub, W. S., … Mancini, G. B. J. (2013). Frequency, Predictors, and Consequences of Crossing Over to Revascularization Within 12 Months of Randomization to Optimal Medical Therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 6(4), 409–418.

Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Acharjee, S., Boden, W. E., Hartigan, P. M., Teo, K. K., Maron, D. J., Sedlis, S. P., … Weintraub, W. S. (2013). Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients A Post-Hoc Analysis From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 62(20), 1826–1833.

As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good.
Maron, D. J., & Boden, W. E. (2014). As REGARDS treatment goal attainment compared with COURAGE: the perfect should not be the enemy of the good. Journal of the American College of Cardiology, 63(16), 1634–35.

Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs.
Maron, D. J., & Hlatky, M. A. (2014). Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs. American Heart Journal, 168(1), 4–5.

Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging.
Shaw, L. J., Berman, D. S., Picard, M. H., Friedrich, M. G., Kwong, R. Y., Stone, G. W., … Douglas, P. S. (2014). Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC. Cardiovascular Imaging, 7(6), 593–604.

Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III).
Doran, B., Guo, Y., Xu, J., Weintraub, H., Mora, S., Maron, D. J., & Bangalore, S. (2014). Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III). Circulation, 130(7), 546–53.

Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)".
Doran, B., Guo, Y., Xu, J., Weintraub, H., Mora, S., Maron, D. J., & Bangalore, S. (2015). Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)". Circulation, 131(19).

Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
Bradley, S. M., Chan, P. S., Hartigan, P. M., Nallamothu, B. K., Weintraub, W. S., Sedlis, S. P., … Spertus, J. A. (2015). Validation of the Appropriate Use Criteria for Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 116(2), 167–73.

Machine learning for risk prediction of acute coronary syndrome.
Vanhouten, J. P., Starmer, J. M., Lorenzi, N. M., Maron, D. J., & Lasko, T. A. (2014). Machine learning for risk prediction of acute coronary syndrome. AMIA ... Annual Symposium Proceedings / AMIA Symposium. AMIA Symposium, 2014, 1940–49.

Primary Prevention of Heart Failure in Older Adults.
Maron, D. J., & Hunt, S. A. (2015). Primary Prevention of Heart Failure in Older Adults. JACC. Heart Failure, 3(7), 529–30.

Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia The Case for Community Equipoise
Stone, G. W., Hochman, J. S., Williams, D. O., Boden, W. E., Ferguson, T. B., Harrington, R. A., & Maron, D. J. (2016). Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia The Case for Community Equipoise. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 67(1), 81–99.

Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.
Collins, S. P., Jenkins, C. A., Harrell, F. E., Liu, D., Miller, K. F., Lindsell, C. J., … Storrow, A. B. (2015). Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool. JACC. Heart Failure, 3(10), 737–47.

Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial)
Padala, S. K., Sidhu, M. S., Hartigan, P. M., Maron, D. J., Teo, K. K., Sperms, J. A., … Boden, W. E. (2015). Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease (A Post Hoc Analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial). AMERICAN JOURNAL OF CARDIOLOGY, 116(10), 1509–15.

Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Sedlis, S. P., Hartigan, P. M., Teo, K. K., Maron, D. J., Spertus, J. A., Mancini, G. B. J., … Boden, W. E. (2015). Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. NEW ENGLAND JOURNAL OF MEDICINE, 373(20), 1937–46.

Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
Cheng-Torres, K. A., Desai, K. P., Sidhu, M. S., Maron, D. J., & Boden, W. E. (2016). Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial? Future Cardiology, 12(1), 35–44.

Treatment of Patients With Stable Ischemic Heart Disease--Reply.
Bangalore, S., Maron, D. J., & Hochman, J. S. (2016). Treatment of Patients With Stable Ischemic Heart Disease--Reply. JAMA, 315(17), 1905–6.

Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions.
Hong, J., Maron, D. J., Shirai, T., & Weyand, C. M. (2015). Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions. International Journal of Clinical Rheumatology, 10(5), 365–81.

Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial
Acharjee, S., Teo, K. K., Jacobs, A. K., Hartigan, P. M., Barn, K., Gosselin, G., … Boden, W. E. (2016). Optimal medical therapy with or without percutaneous coronary intervention in women with stable coronary disease: A pre-specified subset analysis of the Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation (COURAGE) trial. AMERICAN HEART JOURNAL, 173, 108–17.

Evidence-Based Management of Stable Ischemic Heart Disease Challenges and Confusion
Bangalore, S., Maron, D. J., & Hochman, J. S. (2015). Evidence-Based Management of Stable Ischemic Heart Disease Challenges and Confusion. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 314(18), 1917–18.

Why Optimal Medical Therapy Should Be a Universal Standard of Care
Maron, D. J., & Boden, W. E. (2015). Why Optimal Medical Therapy Should Be a Universal Standard of Care. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 66(7), 774–76.

Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia
Mancini, G. B. J., Hartigan, P. M., Shaw, L. J., Berman, D. S., Hayes, S. W., Bates, E. R., … Boden, W. E. (2014). Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia. JACC-CARDIOVASCULAR INTERVENTIONS, 7(2), 195–201.

Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial
Mancini, G. B. J., Hartigan, P. M., Bates, E. R., Chaitman, B. R., Sedlis, S. P., Maron, D. J., … Weintraub, W. S. (2013). Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: Assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. AMERICAN HEART JOURNAL, 166(3), 481–487.

Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial)
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Kolm, P., Goldfarb, D. S., Lorin, J. D., … Weintraub, W. S. (2013). Health Status and Quality of Life in Patients With Stable Coronary Artery Disease and Chronic Kidney Disease Treated With Optimal Medical Therapy or Percutaneous Coronary Intervention (Post Hoc Findings from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 112(11), 1703–1708.

Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
Phillips, L. M., Hachamovitch, R., Berman, D. S., Iskandrian, A. E., Min, J. K., Picard, M. H., … Shaw, L. J. (2013). Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA. JOURNAL OF NUCLEAR CARDIOLOGY, 20(6), 969–975.

Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] Trial)
Maron, D. J., Hartigan, P. M., Neff, D. R., Weintraub, W. S., & Boden, W. E. (2013). Impact of Adding Ezetimibe to Statin to Achieve Low-Density Lipoprotein Cholesterol Goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] Trial). AMERICAN JOURNAL OF CARDIOLOGY, 111(11), 1557–1562.

Revascularization for Silent Ischemia? Another Piece of the Puzzle
Maron, D. J., & Hochman, J. S. (2013). Revascularization for Silent Ischemia? Another Piece of the Puzzle. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(15), 1624–1625.

Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
Farkouh, M. E., Boden, W. E., Bittner, V., Muratov, V., Hartigan, P., Ogdie, M., … Fuster, V. (2013). Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(15), 1607–1615.

Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.
Henry-Okafor, Q., Collins, S. P., Jenkins, C. A., Miller, K. F., Maron, D. J., Naftilan, A. J., … Storrow, A. B. (2012). Soluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes. The Open Biomarkers Journal, 2012(5), 1–8.

In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken? In Mildly Symptomatic Patients, an Invasive Strategy with Catheterization and Revascularization Should Not Be Routinely Undertaken
Maron, D. J., & Ting, H. H. (2013). In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken? In Mildly Symptomatic Patients, an Invasive Strategy with Catheterization and Revascularization Should Not Be Routinely Undertaken. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 6(1), 114–121.

Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies
Collins, S. P., Lindsell, C. J., Jenkins, C. A., Harrell, F. E., Fermann, G. J., Miller, K. F., … Storrow, A. B. (2012). Risk stratification in acute heart failure: Rationale and design of the STRATIFY and DECIDE studies. AMERICAN HEART JOURNAL, 164(6), 825–834.

Clinical pathway: helicopter scene STEMI protocol to facilitate long-distance transfer for primary PCI.
Huang, R. L., Thomassee, E. J., Park, J. Y., Scott, C., Maron, D. J., & Fredi, J. L. (2012). Clinical pathway: helicopter scene STEMI protocol to facilitate long-distance transfer for primary PCI. Critical Pathways in Cardiology, 11(4), 193–198.

A comparison of criterion standard methods to diagnose acute heart failure.
Collins, S. P., Lindsell, C. J., Yealy, D. M., Maron, D. J., Naftilan, A. J., McPherson, J. A., & Storrow, A. B. (2012). A comparison of criterion standard methods to diagnose acute heart failure. Congestive Heart Failure (Greenwich, Conn.), 18(5), 262–271.

Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure.
Henry-Okafor, Q., Collins, S. P., Jenkins, C. A., Miller, K. F., Maron, D. J., Naftilan, A. J., … Storrow, A. B. (2012). Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure. The Open Biomarkers Journal, 5, 9–15.

Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia.
Dresen, W. F., Wells, Q. S., Maron, D. J., & McPherson, J. A. (2012). Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia. Therapeutic Advances in Cardiovascular Disease, 6(3), 115–121.

Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages
Yu, S. S., Lau, C. M., Thomas, S. N., Jerome, W. G., Maron, D. J., Dickerson, J. H., … Giorgio, T. D. (2012). Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages. INTERNATIONAL JOURNAL OF NANOMEDICINE, 7, 799–813.

The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina
Zhang, Z., Kolm, P., Boden, W. E., Hartigan, P. M., Maron, D. J., Spertus, J. A., … Weintraub, W. S. (2011). The Cost-Effectiveness of Percutaneous Coronary Intervention as a Function of Angina Severity in Patients With Stable Angina. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 4(2), 172–U72.

Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?
Maron, D. J., Boden, W. E., Weintraub, W. S., Calfas, K. J., & O'Rourke, R. A. (2011). Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use? Current Treatment Options in Cardiovascular Medicine, 13(1), 16–25.

Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System?
Chaitman, B. R., Hartigan, P. M., Booth, D. C., Teo, K. K., Mancini, G. B. J., Kostuk, W. J., … Boden, W. E. (2010). Do Major Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Trial Differ by Healthcare System? CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 3(5), 476–483.

Having It Both Ways
Bittl, J. A., & Maron, D. J. (2010). Having It Both Ways. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 55(9), 865–866.

Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial
Mancini, G. B. J., Bates, E. R., Maron, D. J., Hartigan, P., Dada, M., Gosselin, G., … Boden, W. E. (2009). Quantitative Results of Baseline Angiography and Percutaneous Coronary Intervention in the COURAGE Trial. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2(4), 320–U97.

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Goldfarb, D. S., Lorin, J. D., Dada, M., … Weintraub, W. S. (2009). Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease. AMERICAN JOURNAL OF CARDIOLOGY, 104(12), 1647–1653.

Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial
Teo, K. K., Sedlis, S. P., Boden, W. E., O'Rourke, R. A., Maron, D. J., Hartigan, P. M., … Weintraub, W. S. (2009). Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease A Pre-Specified Subset Analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 54(14), 1303–1308.

Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)
Boden, W. E., O'Rourke, R. A., Teo, K. K., Maron, D. J., Hartigan, P. M., Sedlis, S. P., … Weintraub, W. S. (2009). Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 104(1), 1–4.

Using COURAGE to treat angina.
Maron, D. J. (2008). Using COURAGE to treat angina. Medscape Journal of Medicine, 10(12), 286-?

Health-Risk Appraisal With or Without Disease Management for Worksite Cardiovascular Risk Reduction
Maron, D. J., Forbes, B. L., Groves, J. R., Dietrich, M. S., Sells, P., & Digenio, A. G. (2008). Health-Risk Appraisal With or Without Disease Management for Worksite Cardiovascular Risk Reduction. JOURNAL OF CARDIOVASCULAR NURSING, 23(6), 513–518.

Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients
Weintraub, W. S., Boden, W. E., Zhang, Z., Kolm, P., Zhang, Z., Spertus, J. A., … Barnett, P. G. (2008). Cost-Effectiveness of Percutaneous Coronary Intervention in Optimally Treated Stable Coronary Patients. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 1(1), 12–U33.

Reducing post-myocardial infarction mortality in the elderly
Boden, W. E., & Maron, D. J. (2008). Reducing post-myocardial infarction mortality in the elderly. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 51(13), 1255–1257.

Does late PCI improve clinical outcome and survival in patients with arterial occlusion after MI?
Maron, D. J. (2007). Does late PCI improve clinical outcome and survival in patients with arterial occlusion after MI? NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 4(5), 250–251.

The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W., … Weintraub, W. S. (2007). The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. AMERICAN JOURNAL OF CARDIOLOGY, 99(2), 208–212.

Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424
Shaw, L. J., Heller, G. V., Casperson, P., Miranda-Peats, R., Slornka, P., Friedman, J., … Berman, D. S. (2006). Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424. JOURNAL OF NUCLEAR CARDIOLOGY, 13(5), 685–698.

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W., … Weintraub, W. S. (2006). Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial: Veterans Affairs Cooperative Studies Program no. 424. AMERICAN HEART JOURNAL, 151(6), 1173–1179.

Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II.
Clark, L. T., Maki, K. C., Galant, R., Maron, D. J., Pearson, T. A., & Davidson, M. H. (2006). Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. Journal of General Internal Medicine, 21(4), 320–326.

Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
Maron, D. J. (2004). Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels? NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 1(1), 18–19.

Flavonoids for reduction of atherosclerotic risk.
Maron, D. J. (2004). Flavonoids for reduction of atherosclerotic risk. Current Atherosclerosis Reports, 6(1), 73–78.

Cholesterol-lowering effect of a theaflavin-enriched green tea extract - A randomized controlled trial
Maron, D. J., Lu, G. P., Cai, N. S., Wu, Z. G., Li, Y. H., Chen, H., … Zhao, J. (2003). Cholesterol-lowering effect of a theaflavin-enriched green tea extract - A randomized controlled trial. ARCHIVES OF INTERNAL MEDICINE, 163(12), 1448–1453.

Postexercise protein intake enhances whole-body and leg protein accretion in humans
Levenhagen, D. K., Carr, C., Carlson, M. G., Maron, D. J., Borel, M. J., & Flakoll, P. J. (2002). Postexercise protein intake enhances whole-body and leg protein accretion in humans. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 34(5), 828–837.

The epidemiology of low levels of high-density lipoproteins cholesterol in patients with and without coronary artery disease
Maron, D. J. (2000). The epidemiology of low levels of high-density lipoproteins cholesterol in patients with and without coronary artery disease. AMERICAN JOURNAL OF CARDIOLOGY, 86(12A), 11L–14L.

Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis
Levenhagen, D. K., Gresham, J. D., Carlson, M. G., Maron, D. J., Borel, M. J., & Flakoll, P. J. (2001). Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 280(6), E982–E993.

Self-reported cardiac risk factors in emergency department nurses and paramedics.
BARRETT, T. W., Norton, V. C., Busam, M., Boyd, J., Maron, D. J., & Slovis, C. M. (2000). Self-reported cardiac risk factors in emergency department nurses and paramedics. Prehospital and Disaster Medicine, 15(2), 14–17.

Percutaneous coronary intervention versus medical therapy for coronary heart disease.
Maron, D. J. (2000). Percutaneous coronary intervention versus medical therapy for coronary heart disease. Current Atherosclerosis Reports, 2(4), 290–296.

Current perspectives on statins
Maron, D. J., Fazio, S., & Linton, M. F. (2000). Current perspectives on statins. CIRCULATION, 101(2), 207–213.

Nonlipid primary and secondary prevention strategies for coronary heart disease
Maron, D. J. (1996). Nonlipid primary and secondary prevention strategies for coronary heart disease. CLINICAL CARDIOLOGY, 19(5), 419–423.

PREVENTIVE MEDICINE IN PRACTICE - THE STATE OF THE ART
Maron, D. J. (1981). PREVENTIVE MEDICINE IN PRACTICE - THE STATE OF THE ART. WESTERN JOURNAL OF MEDICINE, 134(4), 367–372.

Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial)
Gosselin, G., Teo, K. K., Tanguay, J.-F., Gokhale, R., Hartigan, P. M., Maron, D. J., … Boden, W. E. (2012). Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial). AMERICAN JOURNAL OF CARDIOLOGY, 109(7), 954–959.

Galectin 3 complements BNP in risk stratification in acute heart failure
Fermann, G. J., Lindsell, C. J., Storrow, A. B., Hart, K., Sperling, M., Roll, S., … Collins, S. P. (2012). Galectin 3 complements BNP in risk stratification in acute heart failure. BIOMARKERS, 17(8), 706–713.

Can Cardiac Conduction System Disease Be Prevented?
Narayan, S. M., Baykaner, T., & Maron, D. J. (2016). Can Cardiac Conduction System Disease Be Prevented? JAMA Internal Medicine, 176(8), 1093–94.

Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2017). Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiology, 2(1), 47–54.

Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines
Rodriguez, F., Lin, S., Maron, D. J., Knowles, J. W., Virani, S. S., & Heidenreich, P. A. (2016). Use of high-intensity statins for patients with atherosclerotic cardiovascular disease in the Veterans Affairs Health System: Practice impact of the new cholesterol guidelines. AMERICAN HEART JOURNAL, 182, 97–102.

Ethnic differences in achievement of cholesterol treatment goals
Clark, L. T., Maki, K. C., Galant, R., Maron, D. J., Pearson, T. A., & Davidson, M. H. (2006). Ethnic differences in achievement of cholesterol treatment goals. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(4), 320–326.

Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease
Lui, G. K., Rogers, I. S., Ding, V. Y., Hedlin, H. K., MacMillen, K., Maron, D. J., … Fernandes, S. M. (2017). Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease. AMERICAN JOURNAL OF CARDIOLOGY, 119(1), 112–18.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Wiener, D. H. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(17), 2212–41.

Intensity of Statin Treatment and Mortality-Reply.
Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2017). Intensity of Statin Treatment and Mortality-Reply. JAMA Cardiology.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. Journal of the American College of Cardiology, 69(5), 570–91.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons. Journal of the American College of Cardiology, 69(17), 2212–41.

Using Commercial Programs for Lifestyle Intervention: Not Reinventing the Wheel.
Maron, D. J., & Sandhu, A. T. (2017). Using Commercial Programs for Lifestyle Intervention: Not Reinventing the Wheel. Journal of the American College of Cardiology, 70(3), 328–30.

Dietary Patterns and Long-Term Survival: a Retrospective Study of Healthy Primary Care Patients.
Shah, N. S., Leonard, D., Finley, C. E., Rodriguez, F., Sarraju, A., Barlow, C. E., … Maron, D. J. (2017). Dietary Patterns and Long-Term Survival: a Retrospective Study of Healthy Primary Care Patients. The American Journal of Medicine.

PREDICTORS OF STATIN USE FOR PATIENTS WITH LDL CHOLESTEROL ABOVE 190MG/DL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM
Rodriguez, F., Knowles, J., Maron, D., Virani, S., & Heidenreich, P. (2017). PREDICTORS OF STATIN USE FOR PATIENTS WITH LDL CHOLESTEROL ABOVE 190MG/DL: INSIGHTS FROM THE VETERANS AFFAIRS HEALTH CARE SYSTEM. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 69(11), 1693.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
Maron, D. J., Hochman, J. S., O'Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. American Heart Journal, 201, 124–35.

Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial."
Hochman, J. S., & Maron, D. J. (2018). Letter by Hochman and Maron Regarding Article, "'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.". Circulation. Cardiovascular Quality and Outcomes, 11(4), e004742.

Methodological Issues in "Dietary Patterns and Long-Term Survival" Reply
Leonard, D., Shah, N. S., Barlow, C. E., DeFina, L. F., Willis, B. L., & Maron, D. J. (2018). Methodological Issues in "Dietary Patterns and Long-Term Survival" Reply. AMERICAN JOURNAL OF MEDICINE, 131(5), E211.

Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis
Bagai, A., Alexander, K. P., Berger, J. S., Senior, R., Sajeev, C., Pracon, R., … Chaitman, B. R. (2017). Use of troponin assay 99th percentile as the decision level for myocardial infarction diagnosis. AMERICAN HEART JOURNAL, 190, 135–39.

ISCHEMIA: Establishing the Primary End Point
Bangalore, S., Maron, D. J., Reynolds, H. R., Stone, G. W., O'Brien, S. M., Alexander, K. P., & Hochman, J. S. (2018). ISCHEMIA: Establishing the Primary End Point. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(5), e004791.

Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation)
Zhang, Z., Jones, P., Weintraub, W. S., Mancini, G. B. J., Sedlis, S., Maron, D. J., … Spertus, J. A. (2018). Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(5), e003971.

Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System.
Rodriguez, F., Knowles, J. W., Maron, D. J., Virani, S. S., & Heidenreich, P. A. (2018). Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System. The American Journal of Cardiology.

Planning and Conducting the ISCHEMIA Trial: Setting the Record Straight
Maron, D. J., Harrington, R. A., & Hochman, J. S. (2018). Planning and Conducting the ISCHEMIA Trial: Setting the Record Straight. CIRCULATION, 138(14), 1384–86.

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial.
Maron, D. J., Mancini, G. B., Hartigan, P. M., Spertus, J. A., Sedlis, S. P., Kostuk, W. J., … Boden, W. E. (2018). Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. Journal of the American College of Cardiology, 72(19), 2297–2305.

Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial
Scudeler, T. L., Hueb, W. A., Farkouh, M. E., Maron, D. J., de Soarez, P. C., Campolina, A. G., … Kalil Filho, R. (2018). Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trial. INTERNATIONAL JOURNAL OF CARDIOLOGY, 273, 63–68.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design
Bangalore, S., Maron, D. J., Fleg, J. L., O'Brien, S. M., Herzog, C. A., Stone, G. W., … Hochman, J. S. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design. AMERICAN HEART JOURNAL, 205, 42–52.

Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals: Findings From the Cooper Center Longitudinal Study.
Rodriguez, F., Leonard, D., DeFina, L., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2018). Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals: Findings From the Cooper Center Longitudinal Study. JAMA Cardiology.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease (vol 24, pg 1759, 2017)
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2018). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease (vol 24, pg 1759, 2017). JOURNAL OF NUCLEAR CARDIOLOGY, 25(6), 2191–92.

Coronary CT Angiography and Subsequent Risk of Myocardial Infarction.
Sandhu, A. T., & Maron, D. J. (2019). Coronary CT Angiography and Subsequent Risk of Myocardial Infarction. The New England Journal of Medicine, 380(3), 299.

Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2019). Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiology.

Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
Weintraub, W. S., Hartigan, P. M., Mancini, G. B., Teo, K. K., Maron, D. J., Spertus, J. A., … Boden, W. E. (2019). Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease. Circulation. Cardiovascular Quality and Outcomes, 12(2), e005079.

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial.
Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Alexander, K. P., Senior, R., … Maron, D. J. (2019). Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiology.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Allen, J. M. (2019). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 157(3), E131–E161.

ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
Patel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., … Allen, J. M. (2017). ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease. JOURNAL OF NUCLEAR CARDIOLOGY, 24(5), 1759–92.

Relationship between simple markers of insulin resistance and coronary artery calcification
Reaven, G. M., Knowles, J. W., Leonard, D., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2017). Relationship between simple markers of insulin resistance and coronary artery calcification. JOURNAL OF CLINICAL LIPIDOLOGY, 11(4), 1007–12.

Planning and Conducting the ISCHEMIA Trial.
Maron, D. J., Harrington, R. A., & Hochman, J. S. (2018). Planning and Conducting the ISCHEMIA Trial. Circulation, 138(14), 1384–1386.

Using Absolute Event Rates to See What Works in Cardiovascular Medicine.
Bittl, J. A., & Maron, D. J. (2017). Using Absolute Event Rates to See What Works in Cardiovascular Medicine. Journal of the American College of Cardiology, 70(11), 1376–78.

Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing.
Maron, D. J. (2017). Preventive Interventions After Coronary Artery Calcium Scanning: Seeing is Believing. JACC. Cardiovascular Imaging, 10(8), 843–44.

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.
Mancini, G. B., Maron, D. J., Hartigan, P. M., Spertus, J. A., Kostuk, W. J., Berman, D. S., … Boden, W. E. (2019). Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. Journal of the American College of Cardiology, 73(16), 2049–58.

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes
Mancini, G. B. J., Maron, D. J., Hartigan, P. M., Spertus, J. A., Kostuk, W. J., Berman, D. S., … Boden, W. E. (2019). Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 73(16), 2049–58.

Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease
Rodriguez, F., Maron, D. J., Knowles, J. W., Virani, S. S., Lin, S., & Heidenreich, P. A. (2019). Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA CARDIOLOGY, 4(3), 206–13.

Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol >= 190 mg/dl from the Veterans Affairs Health System
Rodriguez, F., Knowles, J. W., Maron, D. J., Virani, S. S., & Heidenreich, P. A. (2018). Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol >= 190 mg/dl from the Veterans Affairs Health System. AMERICAN JOURNAL OF CARDIOLOGY, 122(5), 756–61.

The Comparative Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on 10-Year and Lifetime Atherosclerotic Cardiovascular Disease Risk.
Raygor, V., Garcia, L., Maron, D. J., & Morton, J. M. (2019). The Comparative Effect of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on 10-Year and Lifetime Atherosclerotic Cardiovascular Disease Risk. Obesity Surgery.

Coronary artery calcium testing: A call for universal coverage.
Naghavi, M., Maron, D. J., Kloner, R. A., Berman, D. S., Budoff, M., Superko, H. R., & Shah, P. K. (2019). Coronary artery calcium testing: A call for universal coverage. Preventive Medicine Reports, 15, 100879.

Studies Evaluating Statin Adherence and Outcome Should Adjust for Smoking Persistence and Antiplatelet Treatment Discontinuation-Reply.
Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2019). Studies Evaluating Statin Adherence and Outcome Should Adjust for Smoking Persistence and Antiplatelet Treatment Discontinuation-Reply. JAMA Cardiology.

Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes.
Shaw, L. J., Blankstein, R., Brown, D. L., Dhruva, S. S., Douglas, P. S., Genders, T. S., … Chandrasekhar, Y. (2019). Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes. JACC. Cardiovascular Imaging, 12(7 Pt 1), 1254–78.

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Alexander, K. P., Senior, R., … Jeffries, N. (2019). Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA CARDIOLOGY, 4(3), 273–86.

Dietary Patterns and Long-Term Survival: A Retrospective Study of Healthy Primary Care Patients
Shah, N. S., Leonard, D., Finley, C. E., Rodriguez, F., Sarraju, A., Barlow, C. E., … Maron, D. J. (2018). Dietary Patterns and Long-Term Survival: A Retrospective Study of Healthy Primary Care Patients. AMERICAN JOURNAL OF MEDICINE, 131(1), 48–55.

Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives.
Shapiro, M. D., Maron, D. J., Morris, P. B., Kosiborod, M., Sandesara, P. B., Virani, S. S., … Fazio, S. (2019). Preventive Cardiology as a Subspecialty of Cardiovascular Medicine: JACC Council Perspectives. Journal of the American College of Cardiology, 74(15), 1926–42.

Preventive Cardiology as a Subspecialty of Cardiovascular Medicine JACC Council Perspectives
Shapiro, M. D., Maron, D. J., Morris, P. B., Kosiborod, M., Sandesara, P. B., Virani, S. S., … Fazio, S. (2019). Preventive Cardiology as a Subspecialty of Cardiovascular Medicine JACC Council Perspectives. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 74(15), 1928–42.

Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease
Weintraub, W. S., Hartigan, P. M., Mancini, G. B. J., Teo, K. K., Maron, D. J., Spertus, J. A., … Boden, W. E. (2019). Effect of Coronary Anatomy and Myocardial Ischemia on Long-Term Survival in Patients with Stable Ischemic Heart Disease. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 12(2).

Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
Newman, J. D., Alexander, K. P., Gu, X., O'Brien, S. M., Boden, W. E., Govindan, S. C., … Maron, D. J. (2019). Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial. Circulation. Cardiovascular Quality and Outcomes, 12(11), e006002.

Cardiorespiratory Fitness, Body-Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men.
Clarke, S. L., Reaven, G. M., Leonard, D., Barlow, C. E., Haskell, W. L., Willis, B. L., … Maron, D. J. (2020). Cardiorespiratory Fitness, Body-Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men. The American Journal of Medicine.

Management of Coronary Disease in Patients with Advanced Kidney Disease.
Bangalore, S., Maron, D. J., O'Brien, S. M., Fleg, J. L., Kretov, E. I., Briguori, C., … Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. The New England Journal of Medicine.

Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., Mark, D. B., O'Brien, S. M., Fleg, J. L., … Bangalore, S. (2020). Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. The New England Journal of Medicine.

Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O'Brien, S. M., Boden, W. E., … Rosenberg, Y. (2020). Initial Invasive or Conservative Strategy for Stable Coronary Disease. The New England Journal of Medicine.

Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Spertus, J. A., Jones, P. G., Maron, D. J., O'Brien, S. M., Reynolds, H. R., Rosenberg, Y., … Mark, D. B. (2020). Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. The New England Journal of Medicine.

Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.
Reynolds, H. R., Shaw, L. J., Min, J. K., Spertus, J. A., Chaitman, B. R., Berman, D. S., … Hochman, J. S. (2020). Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial. JAMA Cardiology.

INCIDENTAL CORONARY ARTERY CALCIFICATION IN NON-GATED CT SCANS
Sanders, M., Balla, S., Rodriguez, F., Patel, B., Eng, D. K.-M., Khandwala, N., … Maron, D. J. (2020). INCIDENTAL CORONARY ARTERY CALCIFICATION IN NON-GATED CT SCANS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 75(11), 1806.

The Project Baseline Health Study: a step towards a broader mission to map human health
Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., … Wong, C. A. (2020). The Project Baseline Health Study: a step towards a broader mission to map human health. NPJ DIGITAL MEDICINE, 3(1), 84.

Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease.
Boden, W. E., Hartigan, P. M., Mancini, J., Teo, K. K., Chaitman, B. R., Maron, D. J., … Weintraub, W. S. (2020). Risk Prediction Tool for Assessing the Probability of Death or Myocardial Infarction in Patients With Stable Coronary Artery Disease. The American Journal of Cardiology.

Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials.
Sarraju, A., Maron, D. J., & Rodriguez, F. (2020). Under-Reporting and Under-Representation of Racial/Ethnic Minorities in Major Atrial Fibrillation Clinical Trials. JACC. Clinical Electrophysiology, 6(6), 739–41.

Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
Bangalore, S., Maron, D. J., Stone, G. W., & Hochman, J. S. (2020). Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials. Circulation.

Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
Lopes, R. D., Alexander, K. P., Stevens, S. R., Reynolds, H. R., Stone, G. W., Pina, I. L., … Maron, D. J. (2020). Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial. Circulation.

Invasive or Conservative Strategy for Stable Coronary Disease. Reply.
Antman, E. M., & Braunwald, E. (2020). Invasive or Conservative Strategy for Stable Coronary Disease. Reply. The New England Journal of Medicine, 383(10), e66.

Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply.
Bangalore, S., Maron, D. J., & Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease. Reply. The New England Journal of Medicine, 383(11), 1091–92.

Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop.
Greenland, P., Michos, E. D., Redmond, N., Fine, L. J., Alexander, K. P., Ambrosius, W. T., … Thanassoulis, G. (2020). Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop. JACC. Cardiovascular Imaging.

Nurse Practitioner-Directed Cardio-Diabetes Pilot Program
Bryant, E., Janaszek, K., Nejedly, M., Li, E., Bouvier, M., Schroeder, K., … Maron, D. J. (2020). Nurse Practitioner-Directed Cardio-Diabetes Pilot Program. JNP-JOURNAL FOR NURSE PRACTITIONERS, 16(8), E123–E128.

Invasive or Conservative Strategy for Stable Coronary Disease REPLY
Maron, D. J., & Hochman, J. S. (2020). Invasive or Conservative Strategy for Stable Coronary Disease REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 383(10).

Management of Coronary Disease in Patients with Advanced Kidney Disease Reply
Bangalore, S., Maron, D. J., & Hochman, J. S. (2020). Management of Coronary Disease in Patients with Advanced Kidney Disease Reply. NEW ENGLAND JOURNAL OF MEDICINE, 383(11), 1091–92.

Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
Chaitman, B. R., Alexander, K. P., Cyr, D. D., Berger, J. S., Reynolds, H. R., Bangalore, S., … Hochman, J. S. (2020). Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation.

Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
Bangalore, S., Mancini, G. B., Leipsic, J., Budoff, M. J., Xu, Y., Anthopolos, R., … Maron, D. J. (2020). Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.
Mancini, G. B., Leipsic, J., Budoff, M. J., Hague, C. J., Min, J. K., Stevens, S. R., … Maron, D. J. (2021). Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial. JACC. Cardiovascular Imaging.

Digital Health Interventions for Cardiac Rehabilitation: Systematic Literature Review.
Wongvibulsin, S., Habeos, E. E., Huynh, P. P., Xun, H., Shan, R., Porosnicu Rodriguez, K. A., … Martin, S. S. (2021). Digital Health Interventions for Cardiac Rehabilitation: Systematic Literature Review. Journal of Medical Internet Research, 23(2), e18773.

The Project Baseline Health Study: a step towards a broader mission to map human health.
Arges, K., Assimes, T., Bajaj, V., Balu, S., Bashir, M. R., Beskow, L., … Wong, C. A. (2020). The Project Baseline Health Study: a step towards a broader mission to map human health. NPJ Digital Medicine, 3(1), 84.

Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
Bangalore, S., Maron, D. J., Stone, G. W., & Hochman, J. S. (2021). Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials". Circulation, 143(14), e809–e810.

Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization.
Ali, Z. A., Horst, J., Gaba, P., Shaw, L. J., Bangalore, S., Hochman, J. S., … Stone, G. W. (2021). Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization. Journal of the American Heart Association, e020110.

Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy
Bangalore, S., Mancini, G. B., Leipsic, J., Budoff, M. J., Xu, Y., Anthopolos, R., … Maron, D. J. (2020). Clinical and Quality of Life Outcomes With Chronic Total Occlusion: The ISCHEMIA CTO Substudy. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial.
White, H. D., O'Brien, S. M., Alexander, K. P., Boden, W. E., Bangalore, S., Li, J., … Maron, D. J. (2021). Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial. JAMA Cardiology.

Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial.
Herzog, C. A., Simegn, M. A., Xu, Y., Costa, S. R., Mathew, R. O., El-Hajjar, M. C., … Bangalore, S. (2021). Kidney Transplant List Status and Outcomes in the ISCHEMIA-CKD Trial. Journal of the American College of Cardiology.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design
Maron, D. J., Hochman, J. S., O'Brien, S. M., Reynolds, H. R., Boden, W. E., Stone, G. W., … Rosenberg, Y. (2018). International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. AMERICAN HEART JOURNAL, 201, 124–135.

Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals Findings From the Cooper Center Longitudinal Study
Rodriguez, F., Leonard, D., DeFina, L., Barlow, C. E., Willis, B. L., Haskell, W. L., & Maron, D. J. (2019). Association of Educational Attainment and Cardiovascular Risk in Hispanic Individuals Findings From the Cooper Center Longitudinal Study. JAMA CARDIOLOGY, 4(1), 43–50.

Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
Maron, D. J., Mancini, J., Hartigan, P. M., Spertus, J. A., Sedlis, S. P., Kostuk, W. J., … Boden, W. E. (2018). Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 72(19), 2297–2305.

Letter by Hochman and Maron Regarding Article, ""Faith Healing' and "Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial."
Hochman, J. S., & Maron, D. J. (2018). Letter by Hochman and Maron Regarding Article, ""Faith Healing' and "Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial.". CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 11(4).

Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
Lopes, R. D., Alexander, K. P., Hochman, J. S., & Maron, D. J. (2021). Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial". Circulation, 143(20), e961–e962.

Automated coronary calcium scoring using deep learning with multicenter external validation.
Eng, D., Chute, C., Khandwala, N., Rajpurkar, P., Long, J., Shleifer, S., … Patel, B. N. (2021). Automated coronary calcium scoring using deep learning with multicenter external validation. NPJ Digital Medicine, 4(1), 88.

PREDICTORS OF SETTING OF HEART FAILURE DIAGNOSIS
Tisdale, R., Stafford, R., Maron, D., Hernandez-Boussard, T., Rodriguez, F., Heidenreich, P., & Sandhu, A. (2021). PREDICTORS OF SETTING OF HEART FAILURE DIAGNOSIS. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC.

Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials.
Sarraju, A., Valencia, A., Knowles, J. W., Maron, D. J., & Rodriguez, F. (2021). Diverse Racial/Ethnic Group Underreporting and Underrepresentation in High-Impact Cholesterol Treatment Trials. Circulation, 143(24), 2409–2411.

Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
Chaitman, B. R., Reynolds, H. R., Maron, D. J., & Hochman, J. S. (2021). Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons". Circulation, 144(2), e14–e15.

Disparity in the Setting of Incident Heart Failure Diagnosis.
Sandhu, A. T., Tisdale, R. L., Rodriguez, F., Stafford, R. S., Maron, D. J., Hernandez-Boussard, T., … Heidenreich, P. A. (2021). Disparity in the Setting of Incident Heart Failure Diagnosis. Circulation. Heart Failure, CIRCHEARTFAILURE121008538.

Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity.
Reynolds, H. R., Shaw, L. J., Min, J. K., Page, C. B., Berman, D. S., Chaitman, B. R., … Hochman, J. S. (2021). Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Circulation.

Outcomes of Participants with Diabetes in the ISCHEMIA Trials.
Newman, J. D., Anthopolos, R., Mancini, G. B., Bangalore, S., Reynolds, H. R., Kunichoff, D. F., … Maron, D. J. (2021). Outcomes of Participants with Diabetes in the ISCHEMIA Trials. Circulation.

Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
Lopez-Sendon, J. L., Cyr, D. D., Mark, D. B., Bangalore, S., Huang, Z., White, H. D., … O'Brien, S. M. (2021). Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial. European Heart Journal.

Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia.
Bainey, K. R., Fleg, J. L., Hochman, J. S., Kunichoff, D. F., Anthopolos, R., Chernyavskiy, A. M., … Bangalore, S. (2021). Predictors of Outcome in the ISCHEMIA-CKD Trial: Anatomy versus Ischemia. American Heart Journal.

Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
Reynolds, H. R., Picard, M. H., Spertus, J. A., Peteiro, J., Lopez Sendon, J. L., Senior, R., … Hochman, J. S. (2021). Natural History of Patients With Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study. Circulation, 144(13), 1008–1023.

The Glass Is at Least Half Full.
Maron, D. J., Bangalore, S., & Hochman, J. S. (2021). The Glass Is at Least Half Full. JACC. Cardiovascular Interventions, 14(21), 2350–2352.

Time to Relax the 40-Year Age Threshold for Pharmacologic Cholesterol Lowering.
Heidenreich, P. A., Clarke, S. L., & Maron, D. J. (2021). Time to Relax the 40-Year Age Threshold for Pharmacologic Cholesterol Lowering. Journal of the American College of Cardiology, 78(20), 1965–1967.

Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study.
Califf, R. M., Wong, C., Doraiswamy, P. M., Hong, D. S., Miller, D. P., & Mega, J. L. (2022). Biological and clinical correlates of the patient health questionnaire-9: exploratory cross-sectional analyses of the baseline health study. BMJ Open, 12(1), e054741.

Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial.
Sidhu, M. S., Alexander, K. P., Huang, Z., O'Brien, S. M., Chaitman, B. R., Stone, G. W., … Maron, D. J. (2022). Causes of Cardiovascular and Non-Cardiovascular Death in the ISCHEMIA Trial. American Heart Journal.

Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement?.
Budoff, M. J., Lakshmanan, S., Toth, P. P., Hecht, H. S., Shaw, L. J., Maron, D. J., … Blaha, M. (2022). Cardiac CT angiography in current practice: An American society for preventive cardiology clinical practice statement?. American Journal of Preventive Cardiology, 9, 100318.

Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
Senior, R., Reynolds, H. R., Min, J. K., Berman, D. S., Picard, M. H., Chaitman, B. R., … Hochman, J. S. (2022). Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial. Journal of the American College of Cardiology, 79(7), 651–661.

Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD.
Briguori, C., Mathew, R. O., Huang, Z., Mavromatis, K., Hickson, L. T. J., Lau, W. L., … Bangalore, S. (2022). Dialysis Initiation in Patients With Chronic Coronary Disease and Advanced Chronic Kidney Disease in ISCHEMIA-CKD. Journal of the American Heart Association, e022003.

Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
Mark, D. B., Spertus, J. A., Bigelow, R., Anderson, S., Daniels, M. R., Anstrom, K. J., … Hochman, J. S. (2022). Comprehensive Quality of Life Outcomes with Invasive versus Conservative Management of Chronic Coronary Disease in ISCHEMIA. Circulation.

Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial.
Bangalore, S., Spertus, J. A., Stevens, S. R., Jones, P. G., Mancini, G. B., Leipsic, J., … Maron, D. J. (2022). Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial. Circulation. Cardiovascular Interventions, CIRCINTERVENTIONS121010925.

Timing of Statin Dose: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Haisum Maqsood, M., Messerli, F. H., Waters, D., Skolnick, A. H., Maron, D. J., & Bangalore, S. (2022). Timing of Statin Dose: A Systematic Review and Meta-analysis of Randomized Clinical Trials. European Journal of Preventive Cardiology.

Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
Bangalore, S., Hochman, J. S., Stevens, S. R., Jones, P. G., Spertus, J. A., O'Brien, S. M., … Maron, D. J. (2022). Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function. JAMA Cardiology.

Multi-dimensional characterization of prediabetes in the Project Baseline Health Study.
Chatterjee, R., Kwee, L. C., Pagidipati, N., Koweek, L. H., Mettu, P. S., Haddad, F., … Shah, S. H. (2022). Multi-dimensional characterization of prediabetes in the Project Baseline Health Study. Cardiovascular Diabetology, 21(1), 134.

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline.
Cardoso, R., Shaw, L. J., Blumenthal, R. S., Nasir, K., Ferraro, R., Maron, D. J., … Blankstein, R. (2022). Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline. American Journal of Preventive Cardiology, 11, 100365.

Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study.
Haddad, F., Cauwenberghs, N., Daubert, M. A., Kobayashi, Y., Bloomfield, G. S., Fleischman, D., … Douglas, P. S. (2022). Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study. Journal of Cardiovascular Computed Tomography.

Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
Smilowitz, N. R., Carey, E. P., Shah, B., Hartigan, P. M., Plomondon, M. E., Maron, D. J., … Boden, W. E. (2022). Comparison of Characteristics and Outcomes of Veterans With Stable Ischemic Heart Disease Enrolled in the COURAGE Trial Versus the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. The American Journal of Cardiology.

Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial.
Chaitman, B. R., Cyr, D. D., Alexander, K. P., Pracon, R., Bainey, K. R., Mathew, A., … Bangalore, S. (2022). Cardiovascular and Renal Implications of Myocardial Infarction in the ISCHEMIA-CKD Trial. Circulation. Cardiovascular Interventions, 15(8), e012103.

Screening for participants in the ISCHEMIA trial: Implications for clinical research
Rodriguez, F., Hochman, J. S., Xu, Y., Reynolds, H. R., Berger, J. S., Mavromichalis, S., … Maron, D. J. (2022). Screening for participants in the ISCHEMIA trial: Implications for clinical research. JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 6(1).

Association of Medication Adherence With Health Outcomes in the ISCHEMIATrial.
Garcia, R. A., Spertus, J. A., Benton, M. C., Jones, P. G., Mark, D. B., Newman, J. D., … Maron, D. J. (2022). Association of Medication Adherence With Health Outcomes in the ISCHEMIATrial. Journal of the American College of Cardiology, 80(8), 755–765.

Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients.
Greenland, P., Maron, D. J., & Budoff, M. J. (2022). Insurance Payers Should Cover Selective Coronary Artery Calcium Testing in Intermediate Risk Primary Prevention Patients. Circulation, 146(8), 585–586.

Revascularization and survival in multivessel coronary artery disease in ischemia.
Maron, D. J., Bangalore, S., Reynolds, H. R., & Hochman, J. S. (2022). Revascularization and survival in multivessel coronary artery disease in ischemia. JTCVS Open, 10, 243.

Screening for participants in the ISCHEMIA trial: Implications for clinical research.
Rodriguez, F., Hochman, J. S., Xu, Y., Reynolds, H. R., Berger, J. S., Mavromichalis, S., … Maron, D. J. (2022). Screening for participants in the ISCHEMIA trial: Implications for clinical research. Journal of Clinical and Translational Science, 6(1), e90.

Ischemia With Nonobstructive CoronaryArteries: Insights From the ISCHEMIA Trial.
Reynolds, H. R., Diaz, A., Cyr, D. D., Shaw, L. J., Mancini, G. B., Leipsic, J., … Maron, D. J. (2022). Ischemia With Nonobstructive CoronaryArteries: Insights From the ISCHEMIA Trial. JACC. Cardiovascular Imaging.

Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
Mathew, R. O., Maron, D. J., Anthopolos, R., Fleg, J. L., O'Brien, S. M., Rockhold, F. W., … Bangalore, S. (2022). Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circulation. Cardiovascular Quality and Outcomes, 101161CIRCOUTCOMES122008995.

ISCHEMIA-EXTEND Studies: Rationale and Design.
Anthopolos, R., Maron, D. J., Bangalore, S., Reynolds, H. R., Xu, Y., O'Brien, S. M., … Hochman, J. S. (2022). ISCHEMIA-EXTEND Studies: Rationale and Design. American Heart Journal.

Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials.
Mavromatis, K., Boden, W. E., Maron, D. J., Mancini, G. B., Weintraub, W. S., Gosselin, G., … Hochman, J. S. (2022). Comparison of Outcomes of Invasive or Conservative Management of Chronic Coronary Disease in Four Randomized Controlled Trials. The American Journal of Cardiology.

Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke.
Sandhu, A. T., Rodriguez, F., Maron, D. J., & Heidenreich, P. A. (2022). Use of lipid-lowering therapy preceding first hospitalization for acute myocardial infarction or stroke. American Journal of Preventive Cardiology, 12, 100426.

Opportunistic Incidence Prediction of Multiple Chronic Diseases from Abdominal CT Imaging Using Multi-task Learning
Blankemeier, L., Gallegos, I., Chaves, J. M. Z., Maron, D., Sandhu, A., Rodriguez, F., … Chaudhari, A. S. (2022). Opportunistic Incidence Prediction of Multiple Chronic Diseases from Abdominal CT Imaging Using Multi-task Learning. MEDICAL IMAGE COMPUTING AND COMPUTER ASSISTED INTERVENTION, MICCAI 2022, PT VII. SPRINGER INTERNATIONAL PUBLISHING AG.

Survival After Invasive or Conservative Management of Stable Coronary Disease.
Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O'Brien, S. M., … Maron, D. J. (2022). Survival After Invasive or Conservative Management of Stable Coronary Disease. Circulation.

Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project).
Sandhu, A. T., Rodriguez, F., Ngo, S., Patel, B. N., Mastrodicasa, D., Eng, D., … Maron, D. J. (2022). Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project). Circulation.

Coronary Atherosclerosis Burden and Progression to Guide Clinical Decision Making: A Report from the American College of Cardiology Innovations in Prevention Working Group.
Freeman, A. M., Raman, S. V., Aggarwal, M., Maron, D. J., Bhatt, D. L., Parwani, P., … Shapiro, M. D. (2022). Coronary Atherosclerosis Burden and Progression to Guide Clinical Decision Making: A Report from the American College of Cardiology Innovations in Prevention Working Group. The American Journal of Medicine.

Disparities in Adoption of New Diabetic Therapies with Cardiovascular Benefits.
Vasti, E. C., Basina, M., Calma, J., Maron, D. J., Rodriguez, F., & Sandhu, A. T. (2022). Disparities in Adoption of New Diabetic Therapies with Cardiovascular Benefits. Diabetes Research and Clinical Practice, 110233.

Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial.
Sidhu, M. S., Alexander, K. P., Huang, Z., Mathew, R. O., Newman, J. D., O'Brien, S. M., … Bangalore, S. (2023). Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial. JACC. Cardiovascular Interventions, 16(2), 209–218.

Predictors of Incident HeartFailure Diagnosis Setting: Insights From the Veterans Affairs Healthcare System.
Tisdale, R. L., Fan, J., Calma, J., Cyr, K., Podchiyska, T., Stafford, R. S., … Sandhu, A. T. (2022). Predictors of Incident HeartFailure Diagnosis Setting: Insights From the Veterans Affairs Healthcare System. JACC. Heart Failure.

Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-Gated Chest Cts to Improve Statin Rates
Sandhu, A. T., Rodriguez, F., Ngo, S., Patel, B., Mastrodicasa, D., Eng, D. T., … Maron, D. J. (2022). Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-Gated Chest Cts to Improve Statin Rates. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.

ISCHEMIA-EXTENDed Follow-Up Interim Report
Hochman, J. S., Maron, D. J., Anthopolos, R., Xu, Y., Reynolds, H., Bangalore, S., … Senior, R. (2022). ISCHEMIA-EXTENDed Follow-Up Interim Report. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS.